| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/21/1989 | US4806350 Vaccine formulation |
| 02/21/1989 | US4806348 Method for inducing antibody formation |
| 02/21/1989 | CA1250398A1 Tri-tetra- and pentapeptides, their preparation, and pharmaceutical products containing same |
| 02/21/1989 | CA1250233A1 Moraxella bovis bacterin |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/15/1989 | EP0303463A2 Method to control leukocyte extravasation |
| 02/15/1989 | EP0303406A2 An immunoaffinity substrate |
| 02/15/1989 | EP0303309A2 A genus-specific Listeria antigen identified by monoclonal antibodies |
| 02/15/1989 | EP0303088A2 Purified IgM |
| 02/14/1989 | CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 02/14/1989 | CA1250099A1 Immunogens, antibodies, labeled conjugates and related derivatives for lidocaine and analogs thereof |
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
| 02/09/1989 | WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents |
| 02/09/1989 | WO1989000861A1 Vaccination against rabies-related viruses |
| 02/09/1989 | WO1989000860A1 Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/08/1989 | EP0302801A1 Vaccines of which the characteristic epitope is incorporated in a picorna virus protein, particularly in that of the polio virus |
| 02/08/1989 | EP0302781A1 Process for obtaining staphylococcal capsule polysaccharides, uses of these polysaccharides and strains for putting this process into operation |
| 02/08/1989 | EP0302692A2 Novel process for purification of hepatitis A virions |
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 02/08/1989 | EP0169111B1 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 02/08/1989 | EP0139552B1 Compound labelled with acetylcholine sterase from electrophorus electricus, method for its preparation and its use as a marker in enzyme immuno assays |
| 02/07/1989 | US4803164 Kinase promoter |
| 02/07/1989 | US4803072 Inducing interferon production by administering specific polypeptides; viricides, antitumor agents |
| 02/07/1989 | US4803070 Mixture of emulsion system containing oil, low molecular weight polyol and lecithin and oil in water emulsion containing detergent and endotoxin |
| 02/07/1989 | CA1249781A1 Methods of concentrating ligands and active membranes used therefor |
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections |
| 02/01/1989 | EP0301992A2 Vaccine against group B Neisseria meningitidis, gammaglobulin and transfer factor |
| 02/01/1989 | EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications |
| 02/01/1989 | EP0301458A2 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 |
| 02/01/1989 | EP0301083A1 Retroviral expression vectors and methods for producing hbv antigens |
| 01/31/1989 | US4801689 Isolation from mammalian oxiduct, absorption onto lecithin immobilized on support, then separation |
| 01/31/1989 | US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication |
| 01/31/1989 | CA1249700A1 Compounds of the muramyl-peptide type and medicaments containing them |
| 01/31/1989 | CA1249518A1 Oral immunization of mammals |
| 01/31/1989 | CA1249517A1 Treatment of allergy |
| 01/26/1989 | WO1989000695A1 Method for the diagnosis of infections with detection of lipopolysaccharide antigens |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000166A3 Growth hormone related peptide |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use |
| 01/25/1989 | EP0300007A1 Partial cationization of protein-containing antigens and their use for immunization and desensitization |
| 01/25/1989 | EP0299965A1 Antigenic analogues of platelet activating factor (paf) |
| 01/25/1989 | EP0150350B1 Cross-linked polymers, process for their manufacture and use thereof |
| 01/25/1989 | CN1030588A Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation |
| 01/24/1989 | US4800078 Immunoglobulins |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/18/1989 | EP0299810A1 Process for the production of polypeptides by recombinant DNA |
| 01/18/1989 | EP0299467A1 Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/18/1989 | EP0299082A1 Antiviral agent |
| 01/18/1989 | EP0299057A1 Potentiation of cytotoxic conjugates |
| 01/18/1989 | CN1030443A Multivalent meningococcal class 1 outer-membrane protein vaccine |
| 01/17/1989 | US4798800 Process for isolating human globular domain NC1 of basal membrane collagen from human tissue |
| 01/17/1989 | US4798797 Retrovirus associated with lymphadenopathies and adapted to continuous lines of lymphoblastoid B cells, capable of producing retrovirus continuously and process for their production |
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen |
| 01/17/1989 | US4798719 Method for selection of antigens suitable as in vivo targets for antibodies |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/17/1989 | CA1248874A1 Process for the preparation of antitumoral glycoproteins modified on their carbohydrate units |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000196A1 Virus proteins having reduced o-linked glycosylation |
| 01/12/1989 | WO1989000166A2 Growth hormone related peptide |
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes |
| 01/12/1989 | WO1989000080A1 Gas inlet for a plurality of various reaction gases in reaction vessels |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/12/1989 | DE3721637A1 Gaseinlass fuer eine mehrzahl verschiedener reaktionsgase in reaktionsgefaesse Gas inlet for a plurality of different reactive gases in reaktionsgefaesse |
| 01/11/1989 | EP0298654A2 Use of antibody/antigen interactions to protect or modulate biological activity |
| 01/11/1989 | EP0298633A2 Synthetic polypeptides |
| 01/11/1989 | EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions |
| 01/11/1989 | EP0298280A2 Animal derived cell with antigenic protein introduced therein |
| 01/11/1989 | EP0298210A2 Method for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and reagents used therefor |
| 01/10/1989 | US4797474 Solubilization of protein aggregates |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/10/1989 | CA1248447C Method of inactivating incompatibility-reaction- causing substances |
| 01/10/1989 | CA1248446A1 Process and device for carrying out immune-chemical rapid tests |
| 01/10/1989 | CA1248325A1 Purification apparatus and method employing a regenerable ligand |
| 01/04/1989 | EP0298064A2 Birth control and diagnostic methods |
| 01/04/1989 | EP0297924A2 Recombinant vaccinia virus expressing HSV 1 gB |
| 01/04/1989 | EP0297291A2 Outer membrane protein F of Pseudomonas aeruginosa |
| 01/04/1989 | EP0297110A1 Polypeptides providing protective immunity against malaria |
| 01/04/1989 | CN1030093A Production of peptide |
| 01/04/1989 | CN1030019A Vaccine and its manufacture process |
| 01/04/1989 | CN1030018A Avirulent microbes and uses therefor |
| 01/03/1989 | US4795803 Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 01/03/1989 | US4795635 Vaccine system |
| 01/03/1989 | US4795634 Method for contraception by immunization against the zona pellucida |
| 01/03/1989 | US4795633 Vaccine for swine trichinosis |
| 01/03/1989 | CA1248090A1 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 01/03/1989 | CA1248022A1 Vaccine and method for the production thereof |
| 01/03/1989 | CA1248019A1 Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies |
| 12/29/1988 | WO1988010301A1 Hepatitis b surface antigen vaccine |
| 12/29/1988 | WO1988010300A1 Heterologous viral peptide particle immunogens |
| 12/29/1988 | WO1988010298A1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 12/29/1988 | WO1988010297A1 Cloning of mite allergens |
| 12/29/1988 | WO1988010269A1 Growth factors |